EPHB2 and neoplasm: Even though the survival curve of EphB2(ΔSAM/PDZ) implants appears to have a longer tumor latency than wild-type EphB2, it was not statistically significant (203 vs. 289 day median survival for EphB2 vs. EphB2(ΔSAM/PDZ) respectively).